First Header Logo Second Header Logo

Connection

Christopher Ohl to Female

This is a "connection" page, showing publications Christopher Ohl has written about Female.
Connection Strength

0.171
  1. Koliscak LP, Johnson JW, Beardsley JR, Miller DP, Williamson JC, Luther VP, Ohl CA. Optimizing empiric antibiotic therapy in patients with severe ß-lactam allergy. Antimicrob Agents Chemother. 2013 Dec; 57(12):5918-23.
    View in: PubMed
    Score: 0.032
  2. Luther VP, Bookstaver PB, Ohl CA. Corticosteroids in the treatment of hepatic tuberculosis: case report and review of the literature. Scand J Infect Dis. 2010 Apr; 42(4):315-7.
    View in: PubMed
    Score: 0.025
  3. Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA. Controlling prescription drug expenditures: a report of success. Am J Manag Care. 2007 Aug; 13(8):473-80.
    View in: PubMed
    Score: 0.021
  4. Wofford JL, Ohl CA. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Educ. 2005 Feb 08; 5(1):5.
    View in: PubMed
    Score: 0.018
  5. Moyenuddin M, Williamson JC, Ohl CA. Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy. Curr Gastroenterol Rep. 2002 Aug; 4(4):279-86.
    View in: PubMed
    Score: 0.015
  6. Beardsley J, Vestal M, Rosario N, Meosky K, Johnson J, Luther V, Ohl C, Williamson J. Accuracy of and prescriber perceptions related to documenting antibiotic indications during order entry at an academic medical center. Am J Health Syst Pharm. 2020 02 07; 77(4):282-287.
    View in: PubMed
    Score: 0.012
  7. Wrenn RH, Cluck D, Kennedy L, Ohl C, Williamson JC. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. J Oncol Pharm Pract. 2018 Apr; 24(3):170-175.
    View in: PubMed
    Score: 0.010
  8. Liu P, Ohl C, Johnson J, Williamson J, Beardsley J, Luther V. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program. BMC Infect Dis. 2016 Dec 12; 16(1):751.
    View in: PubMed
    Score: 0.010
  9. Williamson JC, Gibbs HG, Ohl CA, Johnson JW, Beardsley JR, Luther VP, Rokas KE. Reply to Young, Ochi, and Marimuthu. Clin Infect Dis. 2016 Mar 15; 62(6):810-1.
    View in: PubMed
    Score: 0.009
  10. Rokas KE, Johnson JW, Beardsley JR, Ohl CA, Luther VP, Williamson JC. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection. Clin Infect Dis. 2015 Sep 15; 61(6):934-41.
    View in: PubMed
    Score: 0.009
  11. Paddock CD, Finley RW, Wright CS, Robinson HN, Schrodt BJ, Lane CC, Ekenna O, Blass MA, Tamminga CL, Ohl CA, McLellan SL, Goddard J, Holman RC, Openshaw JJ, Sumner JW, Zaki SR, Eremeeva ME. Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis. 2008 Nov 01; 47(9):1188-96.
    View in: PubMed
    Score: 0.006
  12. Moyenuddin M, Ohl CA, Williamson JC, Peacock JE. Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy. J Antimicrob Chemother. 2003 Jan; 51(1):202-3.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.